Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Qilu Pharmaceutical Co., Ltd.
1. To evaluate the safety and tolerability of oral Selatinib Ditosilate Tablets, and explore the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT). 2. To determine the pharmacokinetic profile of single and multi oral Selatinib Ditosilate Tablets . 3. To determine preliminary dose and regimen for phase II study of oral Selatinib Ditosilate Tablets. 4. To assess preliminary antitumor activity .
Age
18–65
Sex
FEMALE
Healthy volunteers
Not accepted